{"disease":{"id":"intrahepatic-cholangiocarcinoma","name":"Intrahepatic cholangiocarcinoma","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":10},"drugs":{"marketed":[{"drug_id":"futibatinib","indication_name":"Intrahepatic cholangiocarcinoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lytgobi","generic_name":"futibatinib","company_name":"Taiho Oncology","drug_phase":"marketed","molecular_target":"Fibroblast growth factor receptor 2","drug_class":"","quality_score":40,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07153783","title":"Interventional AI-Human Collaboration for Liver Tumor Diagnosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":10333,"lead_sponsor_name":"Shengjing Hospital","has_results":false},{"nct_id":"NCT07176962","title":"A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening","phase":"","overall_status":"RECRUITING","enrollment_count":1800,"lead_sponsor_name":"Yingbin Liu, MD, PhD, FACS","has_results":false},{"nct_id":"NCT02834013","title":"Nivolumab and Ipilimumab in Treating Patients With Rare Tumors","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":818,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT07225452","title":"An Exosomal miRNA-based Liquid Biopsy for ICC Detection","phase":"","overall_status":"COMPLETED","enrollment_count":535,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT05896956","title":"The Construction of Clinical Database and Multiomics Biobank Based on a Multicentral Prospective Cohort of Benign and Malignant Biliary Tract Diseases","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT04526106","title":"REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":490,"lead_sponsor_name":"Elevar Therapeutics","has_results":false},{"nct_id":"NCT06290739","title":"A Machine-learning Model to Predict Lymph Node Metastasis of Intrahepatic Cholangiocarcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":483,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT05342194","title":"Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":480,"lead_sponsor_name":"Shanghai Junshi Bioscience Co., Ltd.","has_results":false},{"nct_id":"NCT03768414","title":"Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":452,"lead_sponsor_name":"SWOG Cancer Research Network","has_results":true},{"nct_id":"NCT06342414","title":"An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT07101237","title":"An Exploratory Study on Developing an Integrated Approach Combining Multimodal Imaging and Multi-omics Characterization of Tumor Heterogeneity for Precision Diagnosis and Treatment Optimization in Liver Cancer.","phase":"","overall_status":"RECRUITING","enrollment_count":308,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT07454486","title":"TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Aarhus University Hospital","has_results":false},{"nct_id":"NCT05327907","title":"Establishment of Scoring Model for Early and Differential Diagnosis of Intrahepatic Cholangiocarcinoma","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Qilu Hospital of Shandong University","has_results":false},{"nct_id":"NCT06101277","title":"Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT07208526","title":"A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":270,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT03796819","title":"Routine Lymphadenectomy for Intrahepatic Cholangiocarcinoma","phase":"NA","overall_status":"COMPLETED","enrollment_count":260,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT07161869","title":"Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":250,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT05678218","title":"Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":245,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT04353375","title":"HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":235,"lead_sponsor_name":"Hutchmed","has_results":false},{"nct_id":"NCT07224737","title":"Liquid Biopsy Using Exosomal miRNA Enables Risk Stratification of Potential Metastasis in Patients With Intrahepatic Cholangiocarcinoma.","phase":"","overall_status":"COMPLETED","enrollment_count":230,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT06381648","title":"Detecting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma (LyMIC)","phase":"","overall_status":"COMPLETED","enrollment_count":230,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT04072250","title":"Surgery for Recurrent Intrahepatic Cholangiocarcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":216,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT06990659","title":"Outpatient Versus Inpatient Care Pathway for Intra-arterial Treatment of Primary Liver Cancer (CHOC)","phase":"NA","overall_status":"RECRUITING","enrollment_count":206,"lead_sponsor_name":"University Hospital, Angers","has_results":false},{"nct_id":"NCT04961970","title":"HAIC With FOLFOX Versus Systemic Chemotherapy With GP for Unresectable ICC","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":188,"lead_sponsor_name":"Shi Ming","has_results":false},{"nct_id":"NCT03771846","title":"HAIC Versus Systemic Chemotherapy for Unresectable ICC","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":188,"lead_sponsor_name":"Shi Ming","has_results":false},{"nct_id":"NCT07169734","title":"A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"Alentis Therapeutics AG","has_results":false},{"nct_id":"NCT07479264","title":"A Study on Intratumoral Fibrosis and α-SMA Expression in Intrahepatic Cholangiocarcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":169,"lead_sponsor_name":"First Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT04078230","title":"Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma","phase":"NA","overall_status":"RECRUITING","enrollment_count":168,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT03230318","title":"Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":148,"lead_sponsor_name":"Basilea Pharmaceutica","has_results":true},{"nct_id":"NCT02762721","title":"Analysis of Oncogenes in Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Tumor Tissue Samples","phase":"","overall_status":"COMPLETED","enrollment_count":131,"lead_sponsor_name":"ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)","has_results":false},{"nct_id":"NCT04413734","title":"Combination of Anti-PD-1 Antibody and Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Zhejiang University","has_results":false},{"nct_id":"NCT07152769","title":"Iparomlimab and Tuvonralimab Combined With GC in Advanced ICC","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":104,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT04523402","title":"Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma With High Predict Risk of Lymph Node Metastasis","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Eastern Hepatobiliary Surgery Hospital","has_results":false},{"nct_id":"NCT05247996","title":"TACE Combined With \"Target Immune\" Therapy for First-line Treatment in the Treatment of Intrahepatic Cholangiocarcinoma","phase":"NA","overall_status":"UNKNOWN","enrollment_count":98,"lead_sponsor_name":"The Central Hospital of Lishui City","has_results":false},{"nct_id":"NCT05223816","title":"An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":97,"lead_sponsor_name":"Virogin Biotech Canada Ltd","has_results":false},{"nct_id":"NCT07304388","title":"HAIC Plus Systemic Chemotherapy, Lenvatinib and Toripalimab in Advanced ICC","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":96,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT03684811","title":"A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":93,"lead_sponsor_name":"Forma Therapeutics, Inc.","has_results":true},{"nct_id":"NCT05251662","title":"Sintilimab Combined With GEMOX ± IBI305 (Bevacizumab Biosimilar) Versus GEMOX in Advanced Intrahepatic Cholangiocarcinoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":90,"lead_sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","has_results":false},{"nct_id":"NCT02807181","title":"SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":89,"lead_sponsor_name":"Sirtex Medical","has_results":true},{"nct_id":"NCT03201458","title":"Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":86,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT03942328","title":"Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":85,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT03267940","title":"Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab (ATEZO), CIS, and GEM; and CIS and GEM Alone in Participants With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":85,"lead_sponsor_name":"Halozyme Therapeutics","has_results":true},{"nct_id":"NCT03849469","title":"A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"Xencor, Inc.","has_results":false},{"nct_id":"NCT06946849","title":"Second-line Regimen Combined With Radiotherapy Versus Without Radiotherapy in Patients With Locally Advanced/Oligometastatic ICC After Failure of First-line Treatment：an Open-label, Randomized, Controlled Phase II Clinical Study","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":76,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT05286814","title":"PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05672537","title":"Durvalumab Combined With GemCis Neoadjuvant Therapy of Resectable Intrahepatic Cholangiocarcinoma With High Recurrence Risk","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":70,"lead_sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","has_results":false},{"nct_id":"NCT06721286","title":"Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","has_results":false},{"nct_id":"NCT07063888","title":"A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":66,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT05564403","title":"Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":66,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04295317","title":"PD-1 Antibody (SHR-1210) Plus Capecitabine in Patients with Intrahepatic Cholangiocarcinoma After Surgery","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":65,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}